Search results
Results from the WOW.Com Content Network
Astaxanthin is used as a dietary supplement for human, animal, and aquaculture consumption. [3] Astaxanthin from algae, synthetic and bacterial sources is generally recognized as safe in the United States. [11] The US Food and Drug Administration has approved astaxanthin as a food coloring (or color additive) for specific uses in animal and ...
Eric A. Johnson is a microbiologist and an academic.He is a retired Professor of Bacteriology from the University of Wisconsin-Madison, serving from 1985 to 2020. [1]Johnson, most known for his research on Clostridium botulinum and its neurotoxins in food and industrial microbiology, has developed physiochemical-based methods for basic and applied research of Clostridium botulinum and ...
Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective, also known as the Expert Report, was an expert report published by the World Cancer Research Fund global network in 2007. It reviewed all the evidence about the links between cancer and diet, physical activity and body fat and contains 10 recommendations for ...
Bexarotene, sold under the brand Targretin, is an antineoplastic (anti-cancer) agent used for the treatment of cutaneous T cell lymphoma (CTCL). [4] It is a third-generation retinoid. [5] It was approved by the U.S. Food and Drug Administration (FDA) in December 1999, and the European Medicines Agency (EMA) in March 2001.
Databases for oncogenomic research are biological databases dedicated to cancer data and oncogenomic research. They can be a primary source of cancer data, offer a certain level of analysis (processed data) or even offer online data mining .
Due to the nature of canthaxanthin, relative to astaxanthin (a carotenoid of significant commercial value) these beta-carotene ketolase proteins have been studied extensively. [ 16 ] [ 17 ] An E. coli based production system has been developed, that achieved canthanaxanthin production at 170 mg/L in lab scale fermentation.
The Journal of the National Cancer Institute and The New England Journal of Medicine published articles in 1996 [13] [14] about a trial with a goal to determine if vitamin A (in the form of retinyl palmitate) and β-carotene (at about 30 mg/day, which is 10 times the Reference Daily Intake) supplements had any beneficial effects to prevent cancer.
Astaxanthin – Anthocyanins: 8.5 fold improvement in pharmacokinetics over the complex-free anthocyanins Lycopene – 50 mg phosphatidylcholine: improvement of lycopene pharmacokinetics by 8 fold in patients with coronary heart disease [ 46 ]